Differential ICAM-1 isoform expression regulates the development and progression of experimental autoimmune encephalomyelitis

Molecular Immunology

Volumn 47, Issue 9, 2010, Pages 1692-1700

  Hu, Xianzhen ^a   Barnum, Scott R ^a   Wohler, Jillian E ^a   Schoeb, Trenton R ^b   Bullard, Daniel C ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adhesion molecules; Alternative splicing; ICAM 1; MS EAE

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE COURSE; HISTOPATHOLOGY; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE MUTANT; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; WILD TYPE;

ALTERNATIVE SPLICING; ANIMALS; CELL PROLIFERATION; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN ISOFORMS; T-LYMPHOCYTES, REGULATORY;

MUS;

EID: 77952323359     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.03.005     Document Type: Article

References (40)

1. Anderton S.M., Liblau R.S. Regulatory T cells in the control of inflammatory demyelinating diseases of the central nervous system. Curr. Opin. Neurol. 2008, 21:248-254.
2. Bo L., Peterson J.W., Mork S., Hoffman P.A., Gallatin W.M., Ransohoff R.M., Trapp B.D. Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 1996, 55:1060-1072.
3. Bullard D.C., Hu X., Schoeb T.R., Collins R.G., Beaudet A.L., Barnum S.R. Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J. Immunol. 2007, 178:851-857.
4. Casasnovas J.M., Stehle T., Liu J.H., Wang J.H., Springer T.A. A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:4134-4139.
5. Chen X., Kim T.D., Carman C.V., Mi L.Z., Song G., Springer T.A. Structural plasticity in Ig superfamily domain 4 of ICAM-1 mediates cell surface dimerization. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15358-15363.
6. Dawes R., Petrova S., Liu Z., Wraith D., Beverley P.C., Tchilian E.Z. Combinations of CD45 isoforms are crucial for immune function and disease. J. Immunol. 2006, 176:3417-3425.
7. Diamond M.S., Staunton D.E., Marlin S.D., Springer T.A. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglubulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991, 65:961-971.
8. Dunne J.L., Collins R.G., Beaudet A.L., Ballantyne C.M., Ley K. Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J. Immunol. 2003, 171:6105-6111.
9. Engelhardt B., Briskin M.J. Therapeutic targeting of alpha 4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit?. Eur. J. Immunol. 2005, 35:2268-2273.
10. Giorelli M., De Blasi A., Defazio G., Avolio C., Iacovelli L., Livrea P., Trojano M. Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a. Cell Commun. Adhes. 2002, 9:259-272.
11. Harlan J.M., Winn R.K., Vedder N.B., Doerschuk C.M., Rice C.L. Adhesion: Its Role in Inflammatory Disease 1992, W.H. Freeman and Company, New York.
12. King P.D., Sandberg E.T., Selvakumar A., Fang P., Beaudet A.L., Dupont B. Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative RNA splicing. J. Immunol. 1995, 154:6080-6093.
13. Kirchhausen T., Staunton D.E., Springer T.A. Location of the domains of ICAM-1 by immunolabeling and single-molecule electron microscopy. J. Leukoc. Biol. 1993, 53:342-346.
14. Languino L.R., Duperray A., Joganic K.J., Fornaro M., Thornton G.B., Altieri D.C. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:1505-1509.
15. Lebedeva T., Dustin M.L., Sykulev Y. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr. Opin. Immunol. 2005, 17:251-258.
16. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the central nervous system. J. Neuroimmunol. 1999, 98:77-88.
17. Leung E., Berg R.W., Langley R., Greene J., Raymond L.A., Augustus M., Ni J., Carter K.C., Spurr N., Choo K.H., Krissansen G.W. Genomic organization, chromosomal mapping, and analysis of the 5′ promoter region of the human MAdCAM-1 gene. Immunogenetics 1997, 46:111-119.
18. Lynch K.W. Consequences of regulated pre-mRNA splicing in the immune system. Nat. Rev. Immunol. 2004, 4:931-940.
19. McCourt P.A.G., Ek B., Forsberg N., Gustafson S. Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J. Biol. Chem. 1994, 269:30081-30084.
20. McMurray R.W. Adhesion molecules in autoimmune disease. Sem. Arthr. Rheum. 1996, 25:215-233.
21. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., Willmer-Hulme A.J., Dalton C.M., Miszkiel K.A., O'Connor P.W. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2003, 348:15-23.
22. Miller J., Knorr R., Ferrone M., Houdei R., Carron C.P., Dustin M.L. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med. 1995, 182:1231-1241.
23. Ochietti B., Lemieux P., Kabanov A.V., Vinogradov S., St-Pierre Y., Alakhov V. Inducing neutrophil recruitment in the liver of ICAM-1-deficient mice using polyethyleneimine grafted with Pluronic P123 as an organ-specific carrier for transgenic ICAM-1. Gene Ther. 2002, 9:939-945.
24. Osborn L., Vassallo C., Benjamin C.D. Activated endothelium binds lymphocytes through a novel binding site in the alternately spliced domain of vascular cell adhesion molecule-1. J. Exp. Med. 1992, 176:99-107.
25. Pandiyan P., Zheng L., Ishihara S., Reed J., Lenardo M.J. CD4+CD25+Foxp3+regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+T cells. Nat. Immunol. 2007, 8:1353-1362.
26. Robledo O., Papaioannou A., Ochietti B., Beauchemin C., Legault D., Cantin A., King P.D., Daniel C., Alakhov V.Y., Potworowski E.F., St-Pierre Y. ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. Eur. J. Immunol. 2003, 33:1351-1360.
27. Roebuck K.A., Finnegan A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol. 1999, 66:876-888.
28. Samoilova E.B., Horton J.L., Chen Y. Experimental autoimmune encephalomyelitis in intercellular adhesion molecule-1-deficient mice. Cell. Immunol. 1998, 190:83-89.
29. Sligh J.E., Ballantyne C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., Beaudet A.L. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. 1993, 90:8529-8533.
30. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314.
31. Szalai A.J., Nataf S., Hu X.Z., Barnum S.R. Experimental allergic encephalomyelitis is inhibited in transgenic mice expressing human C-reactive protein. J. Immunol. 2002, 168:5792-5797.
32. Tchilian E.Z., Beverley P.C. Altered CD45 expression and disease. Trends Immunol. 2006, 27:146-153.
33. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., Rainbow D.B., Hunter K.M., Smith A.N., Di Genova G., Herr M.H., Dahlman I., Payne F., Smyth D., Lowe C., Twells R.C., Howlett S., Healy B., Nutland S., Rance H.E., Everett V., Smink L.J., Lam A.C., Cordell H.J., Walker N.M., Bordin C., Hulme J., Motzo C., Cucca F., Hess J.F., Metzker M.L., Rogers J., Gregory S., Allahabadia A., Nithiyananthan R., Tuomilehto-Wolf E., Tuomilehto J., Bingley P., Gillespie K.M., Undlien D.E., Ronningen K.S., Guja C., Ionescu-Tirgoviste C., Savage D.A., Maxwell A.P., Carson D.J., Patterson C.C., Franklyn J.A., Clayton D.G., Peterson L.B., Wicker L.S., Todd J.A., Gough S.C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
34. van Den Engel N.K., Heidenthal E., Vinke A., Kolb H., Martin S. Circulating forms of intercellular adhesion molecule (ICAM)-1 in mice lacking membranous ICAM-1. Blood 2000, 95:1350-1355.
35. von Andrian U.H., Engelhardt B. Alpha4 integrins as therapeutic targets in autoimmune disease. N. Engl. J. Med. 2003, 348:68-72.
36. Wakatsuki T., Kimura K., Kimura F., Shinomiya N., Ohtsubo M., Ishizawa M., Yamamoto M. A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell Adhes. Commun. 1995, 3:283-292.
37. Werner A., Martin S., Gutierrez-Ramos J.C., Raivich G. Leukocyte recruitment and neuroglial activation during facial nerve regeneration in ICAM-1-deficient mice: effects of breeding strategy. Cell Tissue Res. 2001, 305:25-41.
38. Wohler J., Bullard D., Schoeb T., Barnum S. LFA-1 is critical for regulatory T cell homeostasis and function. Mol. Immunol. 2009, 46:2424-2428.
39. Xu H., Gonzalo J.A., St Pierre Y., Williams I.R., Kupper T.S., Cotran R.S., Springer T.A., Gutierrez-Ramos J.C. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J. Exp. Med. 1994, 180:95-109.
40. Yan H.C., Baldwin H.S., Sun J., Buck C.A., Albelda S.M., DeLisser H.M. Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1). J. Biol. Chem. 1995, 270:23672-23680.